Syra Health Corp.
SYRA
$0.07
-$0.01-11.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.14% | 14.07% | 33.04% | 44.73% | 35.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.14% | 14.07% | 33.04% | 44.73% | 35.47% |
| Cost of Revenue | -11.89% | 5.96% | 33.45% | 51.19% | 26.89% |
| Gross Profit | 23.78% | 38.04% | 31.86% | 25.91% | 71.04% |
| SG&A Expenses | -32.70% | -25.67% | -2.18% | 22.04% | 47.24% |
| Depreciation & Amortization | -62.39% | -16.64% | 14.92% | 28.22% | 45.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.87% | -15.15% | 12.92% | 39.80% | 45.93% |
| Operating Income | 70.10% | 64.76% | 21.45% | -30.38% | -69.83% |
| Income Before Tax | 70.21% | 65.18% | 22.64% | -27.94% | -66.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 70.21% | 65.18% | 22.64% | -27.94% | -66.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.21% | 65.18% | 22.64% | -27.94% | -66.30% |
| EBIT | 70.10% | 64.76% | 21.45% | -30.38% | -69.83% |
| EBITDA | 70.23% | 65.40% | 21.96% | -30.41% | -69.84% |
| EPS Basic | 82.03% | 76.91% | 44.03% | 9.83% | -30.31% |
| Normalized Basic EPS | 82.04% | 76.93% | 44.06% | 9.87% | -30.25% |
| EPS Diluted | 82.03% | 76.91% | 44.03% | 9.83% | -30.31% |
| Normalized Diluted EPS | 82.04% | 76.93% | 44.06% | 9.87% | -30.25% |
| Average Basic Shares Outstanding | 69.47% | 70.51% | 63.36% | 55.17% | 6.95% |
| Average Diluted Shares Outstanding | 69.47% | 70.51% | 63.36% | 55.17% | 6.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |